RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...

Researchers used cryo-EM, glycoproteomics, and modeling to generate the atomic structure of a fully glycosylated and membrane ...

Respiratory syncytial virus (RSV), or human respiratory syncytial virus (hRSV), is a common viral respiratory infection that triggers mild, cold-like symptoms. However, at-risk populations ...

Authorities in Kotli have issued a health alert regarding the potential spread of Human Metapneumovirus (HMPV).

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively with age and is more likely among people with other health issues and who ...

Nearly three fourths of infants born during the 2023-2024 respiratory syncytial virus (RSV ... as part of the process. Human editors reviewed this content before publication.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that an oral ...

5. Falsey AR, Walsh EE, House S, et al. Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human ...

Getting vaccinated continues to be the most effective way to prevent infection, local health experts say, as the number of confirmed measles cases grows nationwide.

This flu season has been a difficult one. Not only are a lot of people getting sick, but more people are getting very sick ...

Results from a Phase 2 human challenge study of EDP-323 ... “In Vitro Characterization of Respiratory Syncytial Virus Inhibitors” Location: Bourbon Cataratas do Iguazu, Pavilion C Presenter ...

highlighting the company’s respiratory syncytial virus (RSV) program, will be presented at the 13th International RSV Symposium (RSV 2025) being held March 12-15 at Bourbon Cataratas do Iguazu ...